Glück Conviction Score™ ⓘ
ARMP
Armata Pharmaceuticals, Inc.
ⓘ
Eingeschränkte Aussagekraft — erst 62 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv: Neutral
Sehr niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
78,2
11 neu, 11 erhöht, 31,5M $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 9.64 | -21.4 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 7.13 | +6.3 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 8.03 | EMA50: 8.78 | |
| MACD-Histogramm | Bullisch | 10 % | 0.057 | Bullisch | |
| RSI(14) | Neutral | 10 % | 40.6 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 39.4 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 22.9 | +DI: 9.3 / −DI: 21.1 | |
| Z-Score(60) | Neutral | 5 % | -1.04 | In Range | |
| 52W-Position | Neutral | 5 % | 44.3 % | Hoch 14.80 / Tief 1.84 | |
| Bollinger(20,2σ) | Neutral | 5 % | 24.7 % | Upper 8.49 / Mid 7.89 / Lower 7.28 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0546 | R²=0.26 / annualisiert -144.6 % |
Insider-Transaktionen (12 Monate) ⓘ
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Madison Asset Management, LLC | 2.107.675 | 0 | 2.107.675 | 21.582.592 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 366.028 | 0 | 366.028 | 3.748.127 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 257.992 | 26.088 | 231.904 | 2.641.838 | Aufgestockt | +888,9% | |
| VANGUARD GROUP INC | 357.649 | 0 | 357.649 | 2.246.036 | Neu | +100,0% | |
| 683 Capital Management, LLC | 137.000 | 139.860 | -2.860 | 1.402.880 | Reduziert | -2,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 114.555 | 109.888 | 4.667 | 1.173.971 | Aufgestockt | +4,2% | |
| EDGEWOOD MANAGEMENT LLC | 100.000 | 100.000 | 0 | 1.024.000 | Unverändert | 0,0% | |
| Dauntless Investment Group, LLC | 90.580 | 6.131 | 84.449 | 927.539 | Aufgestockt | +1377,4% | |
| SEI INVESTMENTS CO | 74.192 | 0 | 74.192 | 759.726 | Neu | +100,0% | |
| BlackRock, Inc. | 65.050 | 72.764 | -7.714 | 666.111 | Reduziert | -10,6% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 64.759 | 24.360 | 40.399 | 663.132 | Aufgestockt | +165,8% | |
| Informed Momentum Co LLC | 60.955 | 0 | 60.955 | 624.179 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 60.953 | 45.163 | 15.790 | 624.159 | Aufgestockt | +35,0% | |
| STATE STREET CORP | 50.800 | 50.800 | 0 | 520.192 | Unverändert | 0,0% | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 44.682 | 44.682 | 0 | 457.544 | Unverändert | 0,0% | |
| SeaCrest Wealth Management, LLC | 41.524 | 40.988 | 536 | 425.206 | Aufgestockt | +1,3% | |
| RENAISSANCE TECHNOLOGIES LLC | 38.496 | 68.496 | -30.000 | 394.199 | Reduziert | -43,8% | |
| Grey Ledge Advisors, LLC | 30.000 | 30.000 | 0 | 307.200 | Unverändert | 0,0% | |
| JANE STREET GROUP, LLC | 27.998 | 17.153 | 10.845 | 286.700 | Aufgestockt | +63,2% | |
| Qube Research & Technologies Ltd | 26.628 | 23.356 | 3.272 | 272.671 | Aufgestockt | +14,0% | |
| NORTHERN TRUST CORP | 24.646 | 24.646 | 0 | 252.375 | Unverändert | 0,0% | |
| Hudson Bay Capital Management LP | 17.584 | 0 | 17.584 | 180.060 | Neu | +100,0% | |
| OMERS ADMINISTRATION Corp | 28.125 | 0 | 28.125 | 176.625 | Neu | +100,0% | |
| CAPTRUST FINANCIAL ADVISORS | 13.140 | 13.140 | 0 | 134.554 | Unverändert | 0,0% | |
| BANK OF AMERICA CORP /DE/ | 11.714 | 3.516 | 8.198 | 119.951 | Aufgestockt | +233,2% | |
| CITADEL ADVISORS LLC | 10.786 | 0 | 10.786 | 67.736 | Neu | +100,0% | |
| CITIGROUP INC | 5.160 | 0 | 5.160 | 52.838 | Neu | +100,0% | |
| UBS Group AG | 4.349 | 1.021 | 3.328 | 44.533 | Aufgestockt | +326,0% | |
| MORGAN STANLEY | 3.367 | 2.269 | 1.098 | 34.478 | Aufgestockt | +48,4% | |
| Cornerstone National Bank & Trust Co | 1.428 | 1.428 | 0 | 15.080 | Unverändert | 0,0% | |
| Measured Wealth Private Client Group, LLC | 1.000 | 1.000 | 0 | 10.240 | Unverändert | 0,0% | |
| Trifecta Capital Advisors, LLC | 714 | 714 | 0 | 7.312 | Unverändert | 0,0% | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | 571 | 0 | 5.847 | Unverändert | 0,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 710 | 0 | 710 | 4.459 | Neu | +100,0% | |
| OSAIC HOLDINGS, INC. | 357 | 357 | 0 | 3.656 | Unverändert | 0,0% | |
| Tower Research Capital LLC (TRC) | 277 | 1.604 | -1.327 | 2.836 | Reduziert | -82,7% | |
| Silver Grove Financial Group, Inc. | 200 | 0 | 200 | 2.048 | Neu | +100,0% | |
| BARCLAYS PLC | 154 | 0 | 154 | 1.577 | Neu | +100,0% | |
| WHITTIER TRUST CO | 100 | 100 | 0 | 1.055 | Unverändert | 0,0% | |
| SALEM INVESTMENT COUNSELORS INC | 100 | 0 | 100 | 1.024 | Neu | +100,0% | |
| Geneos Wealth Management Inc. | 92 | 92 | 0 | 942 | Unverändert | 0,0% | |
| MAI Capital Management | 71 | 71 | 0 | 728 | Unverändert | 0,0% | |
| Team Financial Group, LLC | 71 | 71 | 0 | 727 | Unverändert | 0,0% | |
| FMR LLC | 22 | 0 | 22 | 225 | Neu | +100,0% | |
| HRT FINANCIAL LP | 10.595 | 0 | 10.595 | 108 | Neu | +100,0% | |
| SBI Securities Co., Ltd. | 3 | 3 | 0 | 31 | Unverändert | 0,0% | |
| WELLS FARGO & COMPANY/MN | 1 | 1 | 0 | 5 | Unverändert | 0,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| Madison Asset Management, LLC | 2.107.675 | 0 | +100,0% | 21.582.592 | 54,81 |
| VANGUARD CAPITAL MANAGEMENT LLC | 366.028 | 0 | +100,0% | 3.748.127 | 9,52 |
| MILLENNIUM MANAGEMENT LLC | 257.992 | 26.088 | +888,9% | 2.641.838 | 6,71 |
| 683 Capital Management, LLC | 137.000 | 139.860 | -2,0% | 1.402.880 | 3,56 |
| GEODE CAPITAL MANAGEMENT, LLC | 114.555 | 109.888 | +4,2% | 1.173.971 | 2,98 |
| EDGEWOOD MANAGEMENT LLC | 100.000 | 100.000 | 0,0% | 1.024.000 | 2,60 |
| Dauntless Investment Group, LLC | 90.580 | 6.131 | +1377,4% | 927.539 | 2,36 |
| SEI INVESTMENTS CO | 74.192 | 0 | +100,0% | 759.726 | 1,93 |
| BlackRock, Inc. | 65.050 | 72.764 | -10,6% | 666.111 | 1,69 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 64.759 | 24.360 | +165,8% | 663.132 | 1,68 |
| Informed Momentum Co LLC | 60.955 | 0 | +100,0% | 624.179 | 1,59 |
| GOLDMAN SACHS GROUP INC | 60.953 | 45.163 | +35,0% | 624.159 | 1,59 |
| STATE STREET CORP | 50.800 | 50.800 | 0,0% | 520.192 | 1,32 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 44.682 | 44.682 | 0,0% | 457.544 | 1,16 |
| SeaCrest Wealth Management, LLC | 41.524 | 40.988 | +1,3% | 425.206 | 1,08 |
| RENAISSANCE TECHNOLOGIES LLC | 38.496 | 68.496 | -43,8% | 394.199 | 1,00 |
| Grey Ledge Advisors, LLC | 30.000 | 30.000 | 0,0% | 307.200 | 0,78 |
| JANE STREET GROUP, LLC | 27.998 | 17.153 | +63,2% | 286.700 | 0,73 |
| Qube Research & Technologies Ltd | 26.628 | 23.356 | +14,0% | 272.671 | 0,69 |
| NORTHERN TRUST CORP | 24.646 | 24.646 | 0,0% | 252.375 | 0,64 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 45 | 4,3 | 44 |
| 31.12.2025 | ✓ | 36 | 1,3 | 8 |
| 30.09.2025 | ✓ | 28 | 0,8 | 2 |
| 30.06.2025 | ✓ | 29 | 0,7 | 1 |
| 31.03.2025 | ✓ | 26 | 0,7 | 1 |
| 31.12.2024 | ✓ | 24 | 1,4 | 3 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| 683 Capital Management, LLC | 139.860 | 878.321 |
| GOLDMAN SACHS GROUP INC | 45.163 | 283.624 |
| OMERS ADMINISTRATION Corp | 28.125 | 176.625 |
| MILLENNIUM MANAGEMENT LLC | 26.088 | 163.833 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 24.360 | 152.981 |
| Qube Research & Technologies Ltd | 23.356 | 146.676 |
| JANE STREET GROUP, LLC | 17.153 | 107.721 |
| CITADEL ADVISORS LLC | 10.786 | 67.736 |
| Dauntless Investment Group, LLC | 6.131 | 38.503 |
| BNP PARIBAS FINANCIAL MARKETS | 710 | 4.459 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| VANGUARD GROUP INC | 357.649 | 60.611 | +20.4 % | 2.246.036 |
| BlackRock, Inc. | 72.764 | 46.098 | +172.9 % | 456.958 |
| RENAISSANCE TECHNOLOGIES LLC | 68.496 | 27.200 | +65.9 % | 430.155 |
| STATE STREET CORP | 50.800 | 10.500 | +26.1 % | 319.024 |
| SeaCrest Wealth Management, LLC | 40.988 | 6.034 | +17.3 % | 273.800 |
| NORTHERN TRUST CORP | 24.646 | 5.373 | +27.9 % | 154.777 |
| GEODE CAPITAL MANAGEMENT, LLC | 109.888 | 5.342 | +5.1 % | 690.280 |
| BANK OF AMERICA CORP /DE/ | 3.516 | 3.509 | +50128.6 % | 22.080 |
| MORGAN STANLEY | 2.269 | 2.267 | +113350.0 % | 14.250 |
| Tower Research Capital LLC (TRC) | 1.604 | 1.249 | +351.8 % | 10.073 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | 357 | -100 | -21.9 % | 2.242 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 13.05.2026 | Innoviva, Inc. | Aktivist (13D/A) | 82,70 % | 55.467.459 | -0,40 pp | Item 4 in Schedule 13D is hereby supplemented as follows: On May 12, 2026, the Issuer e… |
| 13.05.2026 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 69,70 % | 46.756.659 | -0,40 pp | Item 4 in Schedule 13D is hereby supplemented as follows: On May 12, 2026, the Issuer e… |
| 26.01.2026 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 70,10 % | 46.756.659 | +0,10 pp | Item 4 in Schedule 13D is hereby supplemented as follows: On January 23, 2026, the Issu… |
| 26.01.2026 | Innoviva, Inc. | Aktivist (13D/A) | 83,10 % | 55.467.459 | -0,20 pp | Item 4 in Schedule 13D is hereby supplemented as follows: On January 23, 2026, the Issu… |
| 12.08.2025 | Innoviva, Inc. | Aktivist (13D/A) | 83,30 % | 55.467.459 | -1,90 pp | Item 4 in Schedule 13D is hereby supplemented as follows: On August 11, 2025, the Iss… |
| 12.08.2025 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 70,00 % | 46.756.659 | +7,90 pp | Item 4 in Schedule 13D is hereby supplemented as follows: On August 11, 2025, the Iss… |
| 12.03.2025 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 62,10 % | 46.756.659 | 0,00 pp | Item 4 in Schedule 13D is hereby supplemented as follows: On March 12, 2025, the Issu… |
| 12.03.2025 | Innoviva, Inc. | Aktivist (13D/A) | 85,20 % | 64.178.259 | -0,10 pp | Item 4 in Schedule 13D is hereby supplemented as follows: On March 12, 2025, the Issu… |
| 14.11.2024 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 62,10 % | 46.756.659 | 0,00 pp | |
| 14.11.2024 | Innoviva, Inc | Aktivist (13D/A) | 85,20 % | 64.178.259 | -0,10 pp | |
| 04.03.2024 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 62,10 % | 46.756.659 | 0,00 pp | |
| 04.03.2024 | Innoviva, Inc | Aktivist (13D/A) | 85,30 % | 64.178.259 | Neu | |
| 11.07.2023 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 62,10 % | 46.756.659 | 0,00 pp | |
| 11.07.2023 | Innoviva, Inc. | Aktivist (13D/A) | 85,30 % | 64.178.259 | 0,00 pp | |
| 10.01.2023 | Innoviva, Inc. | Aktivist (13D/A) | 85,30 % | 64.178.259 | +10,37 pp | |
| 10.01.2023 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 62,10 % | 46.756.659 | +27,53 pp | |
| 11.07.2022 | Innoviva, Inc. | Aktivist (13D/A) | 100,00 % | 100 | Neu | |
| 11.07.2022 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | Ausstieg | 0 | Neu | |
| 24.05.2022 | Innoviva Merger Sub, Inc. | Aktivist (13D/A) | Ausstieg | 0 | Neu | |
| 24.05.2022 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 34,57 % | 20.000.000 | 0,00 pp | |
| 24.05.2022 | Innoviva, Inc. | Aktivist (13D/A) | 74,93 % | 57.345.794 | 0,00 pp | |
| 15.03.2022 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 34,57 % | 20.000.000 | -0,13 pp | |
| 15.03.2022 | Innoviva, Inc. | Aktivist (13D/A) | 74,93 % | 57.345.794 | -0,22 pp | |
| 22.02.2022 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 34,70 % | 20.000.000 | 0,00 pp | |
| 22.02.2022 | Innoviva, Inc. | Aktivist (13D/A) | 75,15 % | 57.345.794 | 0,00 pp | |
| 02.02.2022 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 34,70 % | 20.000.000 | -0,20 pp | |
| 02.02.2022 | Innoviva, Inc. | Aktivist (13D/A) | 75,15 % | 57.345.794 | -0,35 pp | |
| 14.06.2021 | Innoviva, Inc. | Aktivist (13D/A) | 75,50 % | 57.345.794 | +0,80 pp | |
| 14.06.2021 | Innoviva Strategic Opportunities LLC | Aktivist (13D/A) | 34,90 % | 20.000.000 | +4,00 pp |
Stammdaten
Armata Pharmaceuticals, Inc., ein klinisches Biotechnologieunternehmen in der Entwicklungsphase, konzentriert sich auf die Entwicklung gezielter Bakteriophagen-Therapeutika gegen antibiotikaresistente Infektionen weltweit. Das Unternehmen entwickelt seine Produkte unter Verwendung seiner proprietären Bakteriophagen-basierten Technologie. Die Produktkandidaten des Unternehmens umfassen AP-SA02 zur Behandlung von Staphylococcus aureus Bakteriämie; AP-PA02 für Pseudomonas aeruginosa; und AP-PA03 zur Behandlung von Pneumonie. Das Unternehmen hat eine Partnerschaftsvereinbarung mit Merck & Co. zur Entwicklung synthetischer Bakteriophagen-Kandidaten zur Bekämpfung noch nicht offenbarter Infektionskrankheitserreger. Das Unternehmen ist in Marina del Rey, Kalifornien ansässig.
Unternehmen & Branche
| Name | Armata Pharmaceuticals, Inc. |
|---|---|
| Ticker | ARMP |
| CIK | 0000921114 |
| Boerse | NYSE |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 04216R102 |
|---|---|
| ISIN | US04216R1023 |
| Typ | Common Stock |
| Marktkapitalisierung | 275,4 Mio. USD |
| Beta | 1,32 |
Bewertung
| FCF-Rendite | -9,6 % vs. -16,7 % (2021) ▲ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 5,85 | 1,24 | – | – | – | |
| FCF-Rendite | -16,7 % | -77,4 % | -47,5 % | -58,9 % | -11,5 % | |
| Qualität & Bilanz | ||||||
| ROIC | -36,5 % | -43,5 % | -1.150,9 % | – | – | |
| Zinsdeckungsgrad | -372,2 | – | -15,6 | – | – | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -115.346.000 | -3,16 | 69.800.000 | -311.586.000 | |
| 2025-12-31 | 10-K | -173.799.000 | -4,80 | 76.882.000 | -218.596.000 | |
| 2025-09-30 | 10-Q | -26.675.000 | -0,74 | 89.516.000 | -95.588.000 | |
| 2025-06-30 | 10-Q | -16.295.000 | -0,45 | 80.790.000 | -69.503.000 | |
| 2025-03-31 | 10-Q | -6.531.000 | -0,20 | 87.250.000 | -53.783.000 | |
| 2024-12-31 | 10-K | -18.916.000 | -0,89 | 86.437.000 | -48.019.000 | |
| 2024-09-30 | 10-Q | -5.481.000 | -0,15 | 98.237.000 | -50.973.000 | |
| 2024-06-30 | 10-Q | 8.986.000 | -0,25 | 108.313.000 | -46.101.000 | |
| 2024-03-31 | 10-Q | -25.021.000 | -0,69 | 120.356.000 | -56.510.000 | |
| 2023-12-31 | 10-K | -69.045.000 | -1,91 | 98.363.000 | -32.065.000 | |
| 2023-09-30 | 10-Q | -31.161.000 | -0,86 | 112.761.000 | -12.386.000 | |
| 2023-06-30 | 10-Q | -3.547.000 | -0,17 | 101.212.000 | 19.143.000 | |
| 2023-03-31 | 10-Q | -14.490.000 | -0,40 | 108.779.000 | 22.447.000 | |
| 2022-12-31 | 10-K | -36.917.000 | -1,08 | 95.834.000 | 36.080.000 | |
| 2022-09-30 | 10-Q | -8.614.000 | -0,24 | 92.881.000 | 45.577.000 | |
| 2022-06-30 | 10-Q | -9.215.000 | -0,26 | 100.984.000 | 53.291.000 | |
| 2022-03-31 | 10-Q | -8.774.000 | -0,30 | 107.765.000 | 61.539.000 | |
| 2021-12-31 | 10-K | -23.155.000 | -0,96 | 69.768.000 | 25.397.000 | |
| 2021-09-30 | 10-Q | -5.419.000 | -0,22 | 42.671.000 | 23.755.000 | |
| 2021-06-30 | 10-Q | -6.194.000 | -0,25 | 48.281.000 | 28.619.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 13.05.2026 | – | -3,16 |
| Q3 2025 | 30.09.2025 | 12.11.2025 | – | -0,74 |
| Q2 2025 | 30.06.2025 | 12.08.2025 | – | -0,45 |
| Q1 2025 | 31.03.2025 | 13.05.2026 | – | -0,20 |
| Q3 2024 | 30.09.2024 | 12.11.2025 | – | -0,15 |
| Q2 2024 | 30.06.2024 | 12.08.2025 | – | -0,25 |
| Q1 2024 | 31.03.2024 | 14.05.2025 | – | -0,69 |
| Q3 2023 | 30.09.2023 | 13.11.2024 | – | -0,86 |
| Q2 2023 | 30.06.2023 | 13.08.2024 | – | -0,17 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 13.05.2026 | 10-Q | – | – | SEC » |
| 25.03.2026 | 10-K | 31.12.2025 | 84 Tage | SEC » |
| 12.11.2025 | 10-Q | 30.09.2025 | 43 Tage | SEC » |
| 12.08.2025 | 10-Q | 30.06.2025 | 43 Tage | SEC » |
| 14.05.2025 | 10-Q | 31.03.2025 | 44 Tage | SEC » |
| 21.03.2025 | 10-K | 31.12.2024 | 80 Tage | SEC » |
| 13.11.2024 | 10-Q | 30.09.2024 | 44 Tage | SEC » |
| 13.08.2024 | 10-Q | 30.06.2024 | 44 Tage | SEC » |
| 07.05.2024 | 10-Q | 31.03.2024 | 37 Tage | SEC » |
| 21.03.2024 | 10-K | 31.12.2023 | 81 Tage | SEC » |
| 14.11.2023 | 10-Q | 30.09.2023 | 45 Tage | SEC » |
| 14.08.2023 | 10-Q | 30.06.2023 | 45 Tage | SEC » |
| 11.05.2023 | 10-Q | 31.03.2023 | 41 Tage | SEC » |
| 16.03.2023 | 10-K | 31.12.2022 | 75 Tage | SEC » |
| 09.11.2022 | 10-Q | 30.09.2022 | 40 Tage | SEC » |
| 11.08.2022 | 10-Q | 30.06.2022 | 42 Tage | SEC » |
| 12.05.2022 | 10-Q | 31.03.2022 | 42 Tage | SEC » |
| 17.03.2022 | 10-K | 31.12.2021 | 76 Tage | SEC » |
| 10.11.2021 | 10-Q | 30.09.2021 | 41 Tage | SEC » |
| 12.08.2021 | 10-Q | 30.06.2021 | 43 Tage | SEC » |
| 13.05.2021 | 10-Q | 31.03.2021 | 43 Tage | SEC » |
| 18.03.2021 | 10-K | 31.12.2020 | 77 Tage | SEC » |
| 12.11.2020 | 10-Q | 30.09.2020 | 43 Tage | SEC » |
| 13.08.2020 | 10-Q | 30.06.2020 | 44 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (27.04.2026)
HOCH Abgang Schlüsselpersonen (27.04.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 27.04.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers… |
| 04.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 15.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 below. With the completion of three Phase 2 trials, the Company is entering a new stage of clinical… |
| 03.10.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 26.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 15.08.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 25.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 20.09.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 19.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers… |
| 05.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 19.12.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 28.03.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 04.08.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.04.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 13.02.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-05 | 216 | 9,85 | 2.128 |
| 2026-04-24 | 187 | 13,53 | 2.530 |
| 2026-04-17 | 3.387 | 11,38 | 38.544 |
| 2026-04-15 | 331 | 12,88 | 4.263 |
| 2026-03-03 | 2 | 11,42 | 23 |
| 2026-02-24 | 864 | 9,54 | 8.243 |
| 2026-02-09 | 1.748 | 7,70 | 13.460 |
| 2026-02-04 | 126 | 7,75 | 977 |